T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 7,788 | 5,245 | 2,552 | 2,545 | 3,069 |
| Cost of Goods | 7,476 | 6,833 | 2,300 | 4,671 | 3,611 |
| Gross Profit | 312 | -1,588 | 252 | -2,126 | -542 |
| Operating Expenses | 9,108 | 9,881 | 9,391 | 12,106 | 12,436 |
| Operating Income | -8,320 | -10,636 | -8,839 | -13,561 | -12,367 |
| Interest Expense | 1,610 | 647 | 1,844 | 1,417 | 1,691 |
| Other Income | 21 | 28 | -2 | 29 | 17 |
| Pre-tax Income | -9,909 | -11,255 | -10,685 | -14,949 | -14,041 |
| Net Income Continuous | -9,909 | -11,255 | -10,685 | -14,949 | -14,041 |
| Net Income | $-9,909 | $-11,255 | $-10,685 | $-14,949 | $-14,041 |
| EPS Basic Total Ops | N/A | -400.00 | -450.00 | -1,100.00 | -1,500.00 |
| EPS Basic Continuous Ops | -14.65 | -380.77 | -444.12 | -1,088.99 | -1,451.49 |
| EPS Diluted Total Ops | N/A | -400.00 | -450.00 | -1,100.00 | -1,500.00 |
| EPS Diluted Continuous Ops | -14.65 | -380.77 | -444.12 | -1,088.99 | -1,451.49 |
| EBITDA(a) | $-7,564 | $-9,871 | $-8,029 | $-12,664 | $-11,484 |